Scribe Therapeutics Inc. · NASDAQ:SCTX

Scribe Therapeutics Inc. shareholders

As of Sep 30, 2026, 60 institutions reported holding Scribe Therapeutics Inc., 85.5% of its shares. Largest: a16z Capital Management, L.L.C., Avoro Capital Advisors LLC and Ra Capital Management, L.P. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Scribe Therapeutics Inc.ChangeFiled
a16z Capital Management, L.L.C.3.08M16.3%newNov 16, 2026
Avoro Capital Advisors LLC2.6M13.7%newNov 16, 2026
Ra Capital Management, L.P.1.8M9.5%newNov 16, 2026
Orbimed Advisors LLC1.35M7.1%newNov 16, 2026
Perceptive Advisors LLC920K4.9%newNov 16, 2026
ARK787K4.2%newNov 13, 2026
Baker Bros. Advisors LP689K3.6%newNov 16, 2026
T. Rowe Price685K3.6%newNov 16, 2026
BlackRock680K3.6%newNov 13, 2026
Vanguard543K2.9%newNov 13, 2026

Scribe Therapeutics Inc. insider trades